DNA: DGCI approves Covaxin clinical trials for 2-18 year olds

The Drugs Controller General of India (DCGI) on Thursday (May 13) approved Bharat Biotech's covariate trials on children aged 2 to 18 years. Bharat Biotech said its Phase II and Phase III trials would be conducted on "525 healthy volunteers".